X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (714) 714
Publication (195) 195
Book Review (103) 103
Conference Proceeding (90) 90
Book Chapter (3) 3
Dissertation (3) 3
Book / eBook (2) 2
Web Resource (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (414) 414
humans (386) 386
oncology (308) 308
hematology (269) 269
middle aged (240) 240
male (228) 228
female (227) 227
aged (224) 224
adult (220) 220
treatment outcome (166) 166
aged, 80 and over (156) 156
article (141) 141
abridged index medicus (116) 116
cancer (110) 110
leukemia (108) 108
prognosis (103) 103
chronic myelogenous leukemia (99) 99
antineoplastic agents - therapeutic use (98) 98
young adult (94) 94
protein kinase inhibitors - therapeutic use (92) 92
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (90) 90
adolescent (89) 89
dasatinib (89) 89
therapy (88) 88
care and treatment (83) 83
chemotherapy (82) 82
hematology, oncology and palliative medicine (80) 80
chronic myeloid leukemia (77) 77
disease-free survival (77) 77
imatinib mesylate (77) 77
hemic and lymphatic diseases (74) 74
imatinib (74) 74
antineoplastic combined chemotherapy protocols - therapeutic use (73) 73
pyrimidines - therapeutic use (62) 62
survival (59) 59
leukemia, myeloid, acute - drug therapy (58) 58
acute myeloid leukemia (56) 56
myelodysplastic syndromes - drug therapy (56) 56
patients (55) 55
survival analysis (55) 55
acute myeloid-leukemia (54) 54
nilotinib (52) 52
myelodysplastic syndromes (51) 51
protein-tyrosine kinases - antagonists & inhibitors (50) 50
risk factors (50) 50
analysis (49) 49
follow-up studies (49) 49
research (49) 49
minimal residual disease (48) 48
retrospective studies (48) 48
survival rate (47) 47
transplantation (47) 47
benzamides (45) 45
mutation (45) 45
acute lymphoblastic leukemia (44) 44
acute myelogenous leukemia (44) 44
chronic myeloid-leukemia (43) 43
piperazines - therapeutic use (43) 43
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (43) 43
remission induction (43) 43
myelodysplastic syndrome (42) 42
cml (41) 41
tyrosine kinase inhibitor (41) 41
cytarabine (40) 40
acute lymphocytic-leukemia (38) 38
myeloid leukemia (38) 38
stem-cell transplantation (38) 38
tyrosine kinase inhibitors (38) 38
decitabine (37) 37
leukemia, myelogenous, chronic, bcr-abl positive - genetics (37) 37
protein kinase inhibitors - administration & dosage (37) 37
antineoplastic agents - administration & dosage (36) 36
dosage and administration (36) 36
hyper-cvad (36) 36
recurrence (35) 35
adults (34) 34
antineoplastic agents - adverse effects (34) 34
antineoplastic combined chemotherapy protocols - adverse effects (34) 34
azacitidine - analogs & derivatives (34) 34
bcr-abl (34) 34
drug therapy (34) 34
fusion proteins, bcr-abl - genetics (34) 34
tyrosine (34) 34
drug administration schedule (33) 33
leukemia, myelogenous, chronic, bcr-abl positive - mortality (33) 33
diagnosis (32) 32
follow-up (32) 32
kaplan-meier estimate (32) 32
outcomes (32) 32
philadelphia chromosome (32) 32
acute lymphoblastic-leukemia (31) 31
stem cells (31) 31
age factors (30) 30
myelodysplastic syndromes - mortality (30) 30
protein kinase inhibitors - adverse effects (30) 30
aml (29) 29
clinical trials and observations (29) 29
cytogenetics (29) 29
drug resistance, neoplasm (29) 29
leukemia, myeloid, chronic-phase - drug therapy (29) 29
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 07/2019
Journal Article
Leukemia & lymphoma, ISSN 1042-8194, 05/2019, pp. 1 - 16
Acute lymphoblastic leukemia (ALL) is a heterogeneous disease with a bimodal distribution. The progresses made in understanding its biology led to the... 
Journal Article
Cancer, ISSN 0008-543X, 07/2017, Volume 123, Issue 13, pp. 2398 - 2403
Journal Article
Cancer, ISSN 0008-543X, 07/2019
BACKGROUNDThe addition of midostaurin to induction chemotherapy improves survival in younger patients with newly diagnosed, FLT3-mutated acute myeloid leukemia... 
Journal Article
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 2016, Volume 14, Issue 3, pp. 10 - 14
Journal Article
Medicine, ISSN 0025-7974, 01/2019, Volume 98, Issue 1, pp. e14011 - e14011
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 02/2019, Volume 60, Issue 3, pp. 668 - 674
We evaluated the impact of molecular monitoring earlier as compared to later in the course of chronic myeloid leukemia (CML) on disease progression and... 
Chronic myeloid leukemia | disease progression | monitoring | healthcare costs | CHRONIC MYELOGENOUS LEUKEMIA | MANAGEMENT | PATTERNS | RESOURCE UTILIZATION | ADHERENCE | TYROSINE KINASE INHIBITORS | ONCOLOGY | IMATINIB | OUTCOMES | HEMATOLOGY | ASSOCIATION
Journal Article
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 06/2015, Volume 13, Issue 6, pp. 12 - 13
Journal Article
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 12/2014, Volume 12, Issue 12, pp. 15 - 17
Journal Article
Journal of medical economics, ISSN 1369-6998, 05/2019, pp. 1 - 6
To develop an economic model to evaluate changes in healthcare costs driven by restricting usage of branded tyrosine kinase inhibitors (TKIs) through... 
Journal Article
Clinical cancer research : an official journal of the American Association for Cancer Research, ISSN 1078-0432, 05/2018, Volume 24, Issue 10, p. 2304
We evaluated the effect on long-term survival of adding rituximab (R) to BEAM (carmustine, etoposide, cytarabine, and melphalan) conditioning with or without... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.